ArticleBiomedicines2022

Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin's Lymphoma Cell Death.

Matheus Fabiao de Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.